Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular alterations associated with improved survival in pancreatic cancer patients treated with radiation or chemotherapy.

Journal of hepato-biliary-pancreatic surgery - 1 Jan 1998

Dergham S T, Dugan M C, Sarkar F H, Vaitkevicius V K

Abstract excerpt

Multiple genetic alterations, several of which may be important prognostic markers, characterize the development of cancer in pancreas. We review our findings from previously published studies with regard to molecular alterations associated with survival differences in patients treated with conventional radiation and chemotherapies used as adjuvant or palliative therapy. K-ras-negative patients with pancreas...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Case-Control Studies

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Cyclins

Share to Enzyme Inhibitors

Share to Gene Expression Regulation, Neoplastic

Share to Genes, ras

Share to Mutation

Share to Tumor Suppressor Protein p53

Source

Identifiers

PMID: 9880774
DOI: 10.1007/s005340050045

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular alterations associated with improved survival in pancreatic cancer patients treated with radiation or chemotherapy.PMID 9880774Read ↗

Prevalence and clinical significance of combined K-ras mutation and p53 aberration in pancreatic adenocarcinoma.Semantic proximity Read ↗

Genetic alterations of K-ras, p53, c-erbB-2, and DPC4 in pancreatic ductal adenocarcinoma and their correlation with patient survival.Semantic proximity Read ↗

K-ras oncogene subtype mutations are associated with survival but not expression of p53, p16(INK4A), p21(WAF-1), cyclin D1, erbB-2 and erbB-3 in resected pancreatic ductal adenocarcinoma.Semantic proximity Read ↗

Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pancreatic cancerSemantic proximity Read ↗

p53, Ki-ras, and DNA ploidy in human pancreatic ductal adenocarcinomas.Semantic proximity Read ↗

Patterns of genetic alterations in pancreatic cancer: a pooled analysis.Semantic proximity Read ↗

Successful growth and characterization of mouse pancreatic ductal cells: functional properties of the Ki-RAS(G12V) oncogene.Semantic proximity Read ↗

Influence of p53 status on radiation and 5-flourouracil synergy in pancreatic cancer cells.Semantic proximity Read ↗

Inhibition of RAC1 GTPase sensitizes pancreatic cancer cells to γ-irradiation.Semantic proximity Read ↗

Pancreatic Cancer Cell Radiation Survival and Prenyltransferase Inhibition: The Role of K-RasSemantic proximity Read ↗

K-Ras-Independent Effects of the Farnesyl Transferase Inhibitor L-744,832 on Cyclin B1/Cdc2 Kinase Activity, G2/M Cell Cycle Progression and Apoptosis in Human Pancreatic Ductal Adenocarcinoma CellSemantic proximity Read ↗

Radiosensitization of the PI3K inhibitor HS-173 through reduction of DNA damage repair in pancreatic cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.